HealthcareServices

D Dimer Testing Market Size Forecast: Revenue and CAGR by 2029

November 24, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The D Dimer Testing Industry Expected To Reach By 2029, Starting From 2025 Levels?

The d dimer testing market size has experienced consistent expansion in recent years. It is anticipated to grow from $1.47 billion in 2024 to $1.54 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.8%. This historical growth can be attributed to the advent of thrombosis research, advancements in laboratory techniques, the clinical validation of d-dimer as a marker, and shifts in diagnostic protocols.

The d dimer testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach “$1.9 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this growth during the forecast period include a rising elderly population, the expansion of point-of-care testing (POCT), its incorporation into risk assessment algorithms, enhanced awareness and educational initiatives, and clearer regulatory guidance and standardization. Key trends expected in the same period involve the use of biomarker combinations for improved diagnosis, an emphasis on obtaining swift and precise results, the role of d-dimer testing in COVID-19 management, the emergence of remote monitoring and at-home testing kits, and the practice of continuous and serial testing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Which Drivers Are Impacting The D Dimer Testing Market?

The d-dimer testing market is projected to expand due to the rising incidence of cancer. Cancer refers to a group of diseases characterized by the uncontrolled proliferation of abnormal cells within almost any bodily organ or tissue, which then exceed their normal limits, potentially spreading to other organs or invading nearby areas. D-dimer testing primarily aids in the diagnosis, monitoring, and treatment of individuals with cancer, as well as in evaluating the likelihood of blood clot formation, by tracking thrombotic events across diverse clinical scenarios. For example, data released by the American Cancer Society, a US-based health organization, in January 2022, projected 609,360 cancer fatalities and 1.9 million new cancer diagnoses in the US for 2022, translating to approximately 1,670 deaths daily. Consequently, the growing occurrence of cancer is a key factor driving the expansion of the d-dimer testing market.

What Are The Primary Types Of Segments Analyzed In The D Dimer Testing Market?

The d dimer testingmarket covered in this report is segmented –

1) By Test: Clinical Laboratory Tests; Point-Of-Care Tests

2) By Product: Analyzers; Reagents And Consumables

3) By Method: Enzyme-linked Immunosorbent Assay (ELISA); Latex-enhanced Immuno-turbidimetric Assays; Fluorescence Immunoassays; Other Testing Method

4) By Application: Deep Vein Thrombosis (DVT); Pulmonary Embolism (PE); Disseminated Intravascular Coagulation (DIC); Other Application

5) By End-User: Hospitals; Academic And Research Institutes; Diagnostic Centers; Other End-User

Subsegments:

1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa); Chemiluminescent Immunoassay (CLIA); Latex Agglutination Assays; Other Laboratory Testing Methods

2) By Point-Of-Care Tests: Rapid Test Kits; Portable Testing Devices; Lateral Flow Assays; Other Point-Of-Care Testing Methods

Which Key Trends Are Expected To Influence The D Dimer Testing Market In The Coming Years?

Leading firms within the D-dimer testing sector are employing strategic alliances to secure exclusive access to D-dimer testing products and enhance their market competitiveness. These alliances involve businesses utilizing each other’s capabilities and assets to achieve shared advantages and accomplishments. An example is the collaboration in March 2022 between SphingoTec GmbH, a German biotechnology company, and Rivaara Labs Pvt Ltd., an Indian medical laboratory and healthcare provider. This agreement grants Rivaara exclusive rights to promote and distribute SphingoTec’s point-of-care tests, which incorporate novel biomarkers, throughout the Indian subcontinent. Such biomarkers include proenkephalin (penKid) for evaluating kidney function, bioactive adrenomedullin (bio-ADM) for assessing endothelial function, and dipeptidyl peptidase 3 (DPP3) as a marker for cardiac depression. These advanced markers are complemented by frequently used parameters like procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

Which Leading Players Are Enhancing Their D Dimer Testing Market Presence Worldwide?

Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

How Does The D Dimer Testing Market Perform Across Key Geographic Regions?

North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the D dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The D Dimer Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12341&type=smp

Browse Through More Reports Similar to the Global D Dimer Testing Market 2025, By The Business Research Company

Direct To Consumer Dtc Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Hemoglobin A1C Testing Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Drugs Of Abuse Doa Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795